Biomea Fusion【BMEA】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.9999

( 3.62% )

買値

1.86

売値

2.00

出来高

729,698

1.87 日の範囲 2.01

1.2905 52 週間の範囲 13.07

時価総額

75.141M

前日終値

1.93

始値

1.91

時刻

375

1.9999

(formt)

最終取引時間

財務取引量

US$ 1,406,137

VWAP

1.927

平均取引量 (3 か月)

2,588,191

発行済株式数

37,572,250

配当利回り

PER

-0.55

1 株当たり利益 (EPS)

-3.68

歳入

純利益

-138.43M

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bi... Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.biomeafusion.com

本社

Wilmington, Delaware, USA

設立

Biomea Fusion Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker BMEA. The last closing price for Biomea Fusion was US$1.93. Over the last year, Biomea Fusion shares have traded in a share price range of US$ 1.2905 to US$ 13.07.

Biomea Fusion currently has 37,572,250 shares in issue. The market capitalisation of Biomea Fusion is US$72.51 million. Biomea Fusion has a price to earnings ratio (PE ratio) of -0.55.

Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA)

In a rodent model of type 2 diabetes (T2D), icovamenib in combination with low-dose semaglutide promoted...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates

Dose-dependent, marked reductions in food intake and significant weight loss observed in obese cynomolgus...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.3299	19.754491018	1.67	2.0299	1.595	1679951	1.86402622	CS
4	-0.5701	-22.1828793774	2.57	3.08	1.58	2408938	1.93874624	CS
12	0.3199	19.0416666667	1.68	3.08	1.2905	2588191	2.23652614	CS
26	-1.8401	-47.9192708333	3.84	4.59	1.2905	1526093	2.37573275	CS
52	-2.8001	-58.3354166667	4.8	13.07	1.2905	1166623	4.08423679	CS
156	-9.9901	-83.3202668891	11.99	43.69	1.2905	869350	11.31046091	CS
260	-18.0001	-90.0005	20	43.69	1.2905	660706	11.25136847	CS

BMEA - Frequently Asked Questions (FAQ)

What is the current Biomea Fusion share price?

The current share price of Biomea Fusion is US$ 1.9999

How many Biomea Fusion shares are in issue?

Biomea Fusion has 37,572,250 shares in issue

What is the market cap of Biomea Fusion?

The market capitalisation of Biomea Fusion is USD 72.51M

What is the 1 year trading range for Biomea Fusion share price?

Biomea Fusion has traded in the range of US$ 1.2905 to US$ 13.07 during the past year

What is the PE ratio of Biomea Fusion?

The price to earnings ratio of Biomea Fusion is -0.55

What is the reporting currency for Biomea Fusion?

Biomea Fusion reports financial results in USD

What is the latest annual profit for Biomea Fusion?

The latest annual profit of Biomea Fusion is USD -138.43M

What is the registered address of Biomea Fusion?

The registered address for Biomea Fusion is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Biomea Fusion website address?

The website address for Biomea Fusion is www.biomeafusion.com

Which industry sector does Biomea Fusion operate in?

Biomea Fusion operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
INKTMiNK Therapeutics Inc	US$ 64.00 (727.94%)	47.85M
FTFTFuture FinTech Group Inc	US$ 3.85 (154.97%)	96.57M
ABVEAbove Food Ingredients Inc	US$ 3.63 (134.19%)	287.35M
AZIAutozi Internet Technology Global Ltd	US$ 0.3652 (79.11%)	199.34M
NEGGNewegg Commerce Inc	US$ 49.21 (71.28%)	3.16M
MISTMilestone Pharmaceuticals Inc	US$ 1.55 (-39.45%)	21.24M
CAPRCapricor Therapeutics Inc	US$ 7.64 (-32.98%)	19.66M
STKHSteakholder Foods Ltd	US$ 2.02 (-32.67%)	1.15M
BGLBlue Gold Limited	US$ 21.15 (-31.53%)	373.97k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 105.00 (-30.69%)	220
WLGSWang and Lee Group Inc	US$ 0.0579 (22.93%)	381.94M
ABVEAbove Food Ingredients Inc	US$ 3.63 (134.19%)	287.35M
NCNANuCana PLC	US$ 0.0502 (-15.91%)	227.31M
BTOGBit Origin Ltd	US$ 0.4386 (51.24%)	213.09M
AZIAutozi Internet Technology Global Ltd	US$ 0.3652 (79.11%)	199.34M